Is adjuvant radiotherapy in early stages (FIGO I-II) of epithelial ovarian cancer a treatment of the past?

Oncology Reports

Volumn 14, Issue 2, 2005, Pages 521-529

  Skirnisdottir, Ingiridur ^a   Nordqvist, Sarah ^a   Sorbe, Bengt ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adjuvant therapy; FIGO stage; Histopathology; Ovarian carcinoma; Prognostic factors; Radiotherapy; Survival; Tumor grade

Indexed keywords

ADENOCARCINOMA; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; COLLOID CARCINOMA; CYSTADENOCARCINOMA; ENDOMETRIOID CARCINOMA; FEMALE; FOLLOW UP; HUMAN; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OVARY TUMOR; PATHOLOGY; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; COMBINED MODALITY THERAPY; CYSTADENOCARCINOMA, SEROUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 24744471881     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.2.521     Document Type: Article

References (31)

1. Winter-Roach B, Hooper L and Kitchener H: Systematic review of adjuvant therapy for early stage (epithelial) ovarian cancer. Int J Gynecol Cancer 13: 395-404, 2003. (Pubitemid 38220656)
2. Young RC: Early-stage ovarian cancer: To treat or not to treat. J Natl Cancer Inst 95: 94-95, 2003.
3. Ozols RF, Rubin SC, Thomas GM and Robboy SJ: Epithelial ovarian cancer. In: Principles and practice of gynecologic oncology. Hoskins WJ, Perez CA and Young RC (eds). 3rd edition. Lippincott, Williams & Wilkins, Philadelphia, pp981-1058, 2000.
4. Baptist Trimbos J, Vergote I, Bolis G, et al: Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European organisation for research and treatment of cancer-adjuvant chemotherapy in ovarian neoplasm trial. J Natl Cancer Inst 95: 113-125, 2003. (Pubitemid 36193260)
5. Menczer J: Reflections on the FIGO surgical staging of invasive epithelial ovarian cancer. Eur J Gynecol Oncol 24: 215-222, 2003.
6. Gadducci A, Sartori E, Maggino T, et al: Analysis of failures in patients with stage I ovarian cancer: An Italian multicenter study. Int J Gynecol Cancer 7: 445-450, 1997. (Pubitemid 28020705)
7. Schueler JA, Trimbos JB, Hermans J and Fieuren GJ: The yield of surgical staging in presumed early stage ovarian cancer: Benefits or doubts? Int J Gynecol Cancer 8: 95-102, 1998. (Pubitemid 28246511)
8. Zanetta G, Rota S, Chiari S, et al: The accuracy of staging: An important prognostic determinator in stage I ovarian carcinoma. Ann Oncol 9: 1097-1101, 1998. (Pubitemid 28518148)
9. Vergote I, Brabanter JD, Fyles A, et al: Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 357: 176-182, 2001. (Pubitemid 32108089)
10. Kristensen GB, Kildal W, Abeler VM, et al: Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer. Ann Oncol 14: 1494-1500, 2003. (Pubitemid 37304603)
11. Fyles A, Bolis G, Ferraris C, Bolla M and Parazzini F: Current controversies in cancer: Is abdomino-pelvic radiation therapy the optimal treatment for completely resected stage I and II high risk ovarian cancer? Eur J Cancer 33: 12-19, 1997. (Pubitemid 27099560)
12. Ozols RT, Rubin SC, Thomas G and Rubboy S: Epithelial ovarian cancer. In: Principles and Practice of Gynecologic Oncology. Hoskins WJ, Perez CA, and Young RC (eds). 2nd edition. Lippincott-Raven, Philadelphia, pp941-1018, 1997.
13. Junor EJ, Hole DJ, McNuIty L, Mason M and Young J: Specialist gynecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br J Obstet Gynaecol 106: 1130-1136, 1999. (Pubitemid 29495411)
14. Kolomainen DF, A'Hern R, Coxon FY, et al: Can patients with relapsed, previously untreated stage I epithelial ovarian cancer be successfully treated with salvage therapy? J Clin Oncol 16: 3113-3118, 2003. (Pubitemid 46606292)
15. FIGO Annual report on the results of treatment in gynecological cancer. J Epidem Biostat 3: 76, 1998.
16. Cannistra SA: Cancer of the ovary. N Engl J Med 329: 1550-1559, 1993.
17. Marsden DE, Friedlander M and Hacker NF: Current management of epithelial ovarian carcinoma: A Review. Semin Surg Oncol 19: 11-19, 2000. (Pubitemid 30439310)
18. Young RC, Walton LA, Ellenberg SS, et al: Adjuvant therapy in stage I and II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med 322: 1021-1027, 1990. (Pubitemid 20146659)
19. Dembo AJ, Bush RS and De Boer G: Therapy in stage I ovarian cancer. Am J Obstet Gynecol 141: 231-233, 1981.
20. Vergote IB, Vergote-De Vos LN, Abeler VM, et al: Randomized trial comparing cisplatin with radioactive phosphorous or whole-abdomen irradiation as adjuvant treatment of ovarian cancer. Cancer 69: 741-749, 1992.
21. Dembo AJ, Bush RS, Beale HA, et al: The Princess Margaret Hospital study of ovarian cancer: Stages I, II and asymptomatic III presentations. Int J Radiât Oncol Biol Phys 63: 240-254, 1979.
22. Bolis G, Colombo N, Pecorelli S, et al: Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). GICOG Gruppo Interregionale Collaborativo in Ginecologia Oncologica. Ann Oncol 6: 887-893, 1995.
23. Kojs Z, Glinski B, Reifuss, et al: Results of randomized prospective trial comparing postoperative abdomino-pelvic radiotherapy with postoperative chemotherapy in early ovarian cancer. Cancer Radiother 5: 5-11, 2001. (Pubitemid 32158383)
24. Chiara S, Conte P, Franzone P, et al: High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy. Am J Clin Oncol 17: 72-76, 1994. (Pubitemid 24062739)
25. Colombo N and Pecorelli S: What have we learned from ICON1 and ACTION? Int J Gynecol Cancer 13: 140-143, 2003. (Pubitemid 38228755)
26. Green JA: Early ovarian cancer - time for a rethink on stage? Gynecol Oncol 90: 235-237, 2003.
27. Dembo AJ: Epithelial ovarian cancer: The role of radiotherapy. Int J Radiat Oncol Biol Phys 22: 835-842, 1992.
28. Sell A, Bertelsen K, Andersen JE, Ströyer I and Panduro J: Randomized study of whole-abdomen irradiation versus pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer. Gynecol Oncol 37: 367-373, 1990. (Pubitemid 20182983)
29. Morton GC and Thomas GM: Is there a place for whole abdominal radiotherapy in the management of ovarian cancer? Ann Acad Med 25: 429-436, 1996. (Pubitemid 26265410)
30. Ozols RF, Bookman MA, Connolly DC, et ai. Focus on epithelial ovarian cancer. Cancer Cell 5: 19-24, 2004.
31. Proveda A: Ovarian cancer treatment: what is new? Int J Gynecol Cancer 13: 241-250, 2003.